ArticleAnnals of surgical oncology2026
Development and Validation of a Frailty Risk Prediction Model for Preoperative Non-Small-Cell Lung Cancer Patients: A Cross-Sectional Study.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
purposeFrailty is increasingly recognized as a predictor of poor surgical outcomes, yet its preoperative assessment in patients with non-small-cell lung cancer (NSCLC) remains challenging. This study aimed to develop and validate a high-performance predictive model for assessing frailty risk using routinely available clinical parameters and machine learning (ML) techniques.
methodsThis single-center, cross-sectional study enrolled 489 preoperative patients with NSCLC hospitalized from April to October 2024. Participants were randomly divided into training (n = 342) and validation (n = 147) sets. Frailty was assessed using the FRAIL scale. We developed a logistic regression-based nomogram and compared it with six ML models. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis.
resultsFrailty/pre-frailty prevalence was 36.1%. Logistic regression identified age, body mass index, comorbidity grade, fatigue, walking difficulty, single-breath diffusing capacity of the lung for carbon monoxide and the triglyceride-glucose (TyG) index as independent predictors. Although the nomogram achieved an AUC of 0.77 (95% confidence interval 0.69-0.85) in the validation set, the Light Gradient Boosting Machine (LGBM) model demonstrated superior discrimination, with an AUC of 0.965 in the training set and 0.807 in the validation set. Feature importance analysis highlighted the TyG index, comorbidity grade, and maximal voluntary ventilation as top predictors.
conclusionsThis study developed a robust frailty risk prediction framework. The integration of ML algorithms with objective physiological markers (TyG index and respiratory reserve) significantly enhanced predictive accuracy over traditional methods, providing a reliable tool for preoperative risk stratification in patients with NSCLC.
Indexed as
Identifiers
41714831What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.